The abstract is read at the publisher; the summary is JClub's.
Smarter Care Virginia was linked to a 10.4% fewer share of patients receiving at least one of nine low-value services in Virginia, with a -1.1 percentage-point absolute reduction.
- Why it matters: Low-value care costs over $100 billion annually and persists despite evidence of clinical and financial harms, but statewide, health-system–partnered feasibility is uncertain.
- What they did: In a difference-in-differences quality improvement study, 6 intervention health systems were compared with 12 control systems in Virginia from 2019 to 2022 using patient-attributed rates for nine clinician-selected low-value services.
- The result: After the intervention, low-value service use fell from 10.5% to 8.5% in the intervention group versus 10.7% to 9.1% in controls, with no statistically significant change in adverse events or spending.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.